Nanomaterials-based
Soft Electronics in Medicine
Seoul National University
Chemical and Biological Engineering
Dae-Hyeong Kim
100 mm
2D Graphene 2D Nanomembranes
0D Nanodots 1D Nanowires
Serpentine Percolated structure
Ultrathin Buckling
Additive transfer Intaglio transfer Langmuir Blodgett Molding/templating
Memory Display
Sensors Actuator
50 nm 50 nm
100 mm 200 mm
10 mm
1 nm
500 nm
100 mm
1 mm
30 μm
2 mm
5 mm 3 mm
Device Integration Deformable Design
Assembly Nanomaterials
Nanomaterials, their Assembly, and Soft Devices
ChemNanoMat AOP (2016)
Prosthetic eye ECoG
Prosthetic skin
ECG recording, pacing, ablation
Wearable energy device
Drug diffusion
Transdermal drug delivery Angioplasty
Drug delivery Vital sign
sensing
Home rehabilitation Data storage
EEG
Invasive: Implantable, Minimally invasive device Noninvasive: Wearable devices
Optogenetics
Heat Electricity
Wireless communication Remote healthcare
“Clinical Translation” of “Soft Bioelectronics”
Advanced Materials 28, 4203 (2016)
2. Surgical Tool for Colon Cancer 1. Cardiac Mesh for HF
3. Electronic Patch for Diabetes
4. Patient-Device Interface
Dead
Cardiomyocyte
Myocardial Infarction
& Arrhythmia
LV-RV
Non-synchronization
Cardiac Diseases (Vascular/MI, Arrhythmia/VT, &
LV-RV non-synchronization/reduced LV function)
① Angioplasty
& Stent
② HR Mapping
& RF Ablation
③ Global CRT
RRAM
BES (deflated state)
Temperature sensor Angioplasty for canine common carotid artery
0.6 mm 5 mm
Sheath
Canine common carotid artery
BES Implantation site 10 mm
Inflation with contrast agents Deflation
Catheter with BES 20 mm
Canine common carotid artery
Deployed BES
Volume-rendered CT image
Retractor
20 mm
ACS Nano 9, 5937 (2015)
Minimally Invasive Surgery
(e.g., Angioplasty using Catheter and Stent)
Epicardial Mapping Electrode Array
Science Translational Medicine 2, 24ra22 (2010)
Minimally Invasive Surgical Tools
Time (s)
0 30 60 90 120
V olta ge ( V )
0.0 0.4 0.8 1.2 1.6
Time (s)
20 40 60 80
R (k)
10 12 14
5mm 5mm 2mm
Contact sensor Contact
sensor
CPDMS 3mm
Au
off off
on cont.
Press. Sens.
off off
Impedance cont. sens.
off off off off off
on on on on on on
deflation inflation 4cm contrast agent injection
off on
off
P (kPa)
1200
0 600 Cross-
section
0.0 0.5 1.0 1.5
0.00 0.25
Z (mm)
Y(mm) k=0 at (Z=0.61; Y=0.13)
Deflated balloon
Proc. Nat. Acad. Sci. USA 109, 19910 (2012)
Current Treatments for HF
Biventricular pacing rapidly enhances cardiac functions, alleviates symptoms, and improves long- term survival in numerous cases
Two point electrodes on both ventricles may be too
localized to completely restore the global synchronous contractions (need global resynchronization pacing)
• Electrical stimulation therapy
• Passive ventricular restraint
A device encircling the heart
To share myofiber stress as well as reduce the size of cardiac chambers
But over-compression interferes breathing and may cause arrhythmia (need extreme softness)
Multiple point stimulation
Appropriate pressure
Science Translational Medicine 8, 344ra86 (2016)
0 5 10 15 20 25 0
3,000 6,000 9,000 12,000
LE Ag NW conc. (vol%)
σ(S/cm)
Max Cond. ~ 30,000 S/cm Stretchability ~ > 100%
Commercial 1~100 S/cm
Purkinje
network
MyocardiumElectrophysiological Conduction
Tensile strain (%)
Stress (kPa)
Epicardium Cardiac mesh
20 10
0 5 15
2 0 8 10
4 6
Mechanically-matched Design of the Artificial Epicardium
Stretchable Conductive Cardiac Mesh for Global Resynchronization Therapy for Heart Failure Model
Ag NWs with NOBF4
Ag
PVP NOBF4
Ag NWs in DMF
LE Ag NWs in toluene
SBS O N
LE Ag NWs with SBS elastomer
HN HAm
N O+ B-F F F F
LE Ag NWs in toluene
50 mg/mL Metal: 100,000 S/cm
Customized Design and Biocompatibility
Science Translational Medicine 8, 344ra86 (2016)
Wrap epicardial mesh
No wrap (control)
1 cm 5 mm
RV
+ -
LV I
S S
L0 = 60 mm
60 55 50 39 34 30 24 20 3 9 -3 -2 44 Max prin.
strain (%)
(1) No significant pressure on ventricle
(2) Histology 3 weeks after
implantation
Science Translational Medicine 8, 344ra86 (2016)
Resynchronization Therapy in Post-MI
Science Translational Medicine 8, 344ra86 (2016)
Recording, Pacing, and Defibrillation
Pre MeshP Pre MeshP Control Post-MI
60
40
20 80
0
***
QR Sd (ms )
QRSd QRSd
Mesh Pacing
Q R
S
Q R
S
• Recording - Surface ECG - Catheter ECG - Mesh ECG
• Defibrillation
• Pacing
- Wide QRSd in post-MI model
- Epicardial mesh reduces QRSd
Conventional electrode
Epicardial mesh
Surface ECG, lead II 2,000 ms 4,000 ms
a' v
a' v
v v
p p
a' v v p
Reduction of Mechanical Wall Stress
Systole
Diastole
160 200 240
1.0 0.5 1.5 2.0 2.5
Time (ms) RAP MeshP
55 60 65
5.0 4.5 5.5 6.0 6.5
Wall stress (x102 kdyn/cm2 )Wall stress (x102 kdyn/cm2 )
Control
0 1 2
0 100
200 300
0 50 100
Post-MI 6
0 4
2
0 100
200 300
0 50 100
• Longitudinal wall stress was derived from simultaneous recordings of LV pressure and myocardial strains during RA pacing and Mesh pacing
• Reduced host myocardial wall stress by acting as an additioal structural component to the LV
Appropriate pressure
Colonoscopy
Eugene Gastroenterology Terese Winslow U.S. Govt.
Colon cancer
3 rd popular cancer (12.9%) in Korea Diagnosis
Visual observation
Surgical resection
Smart Endoscope
Nature Communications 6,10059 (2015)
Endoscope
Multifunct. NPs Cancer cells NIR laser (PTT)
Temp.
sensor Contact
sensor Viability sensor Ablation elect.
Tumor/pH sensor
Red laser (PDT)
Visible light TP bio- electronics
GP/Ag NW/GPIrOxEpoxy
Au NR
MSS FL dye Antibody
PDT dye PNIPAAm
Dox
Transparent bio-electronics
Multifunctional Nanoparticles
- Contact sensor - Tumor sensor - pH sensor
- Ablation electrode - Temperature sensor - Viability sensor
- Active targeting - Fluorescent imaging - Photothermal therapy - Photodynamic therapy - Chemotherapy
- Combined therapy
Integration to Endoscope
Nature Communications 6,10059 (2015)
Radius of curvature (mm) Twisting angle (o)
2 3 4 5 6 7
-25 ΔR/R0(%)
0 25 50
After bending After twisting 0 15 30 45 60 75
8 90
105 9 Frequency (Hz)
102 1
Before sterilization After sterilization
104
10 103
0 1,000 2,000 3,000
Impedance (Ω)
At 120 ℃, 200 kPa
ΔR/R0 (%)
1
Number of cycles 50
0
-50 10 100 1,000
Bending Twisting 100
0
Radius of curvature (mm)
2 4 6 8
0 2000 4000 6000 8000
ΔR/R0(%)
GP ITO 2 mm Transparent
bio-electronics PI/Au
interconnect
Contact pad
2 mm Water
outlet
Laser
2 mm 2 mm
Sterilization
Transfer to endoscope Peel off
Sterilize
GP-based Transparent System
Nature Communications 6,10059 (2015)
250 μm
Temp.
sensor Contact
sensor Viability
sensor Ablation elect.
Tumor/pH sensor
On Off
Temperature (℃)
Time (s) 25
30 35 40 45
0 1 2 3 4Δ0R/R(%)
160 120 80 40 50 55 5
Time (s) 100 200
ΔZ/Z0(%)
Contact On
Off
300 400
400 500 600
200 0
5 mm
Before After
Tumor
Dermis Blood Muscle 5.5
pH
6.0 6.5 7.0 7.5
8.0 *p < 0.001 N = 8 * *
* 8.5
Frequency (Hz)
Impedance (Ω)
104
Normal tissue Tumor tissue
105 104
105 106
103
106 107
*p < 0.001 N = 8
1 2 3 4 5 6 7 8 Position 1
3 10 30
Impedance (kΩ)
1 Position
pH
2 3 4 5 6 7 8 8.0
7.0
6.0
5.0
4
3 5 6 7
2 1
Porcine intestine
4 mm 1 2 3 Position4 5
Impedance (kΩ)
30
10
6 7 100
300
MaxMin
4 5
2
1 3
7
6 8
4 5
2
1 3
7
6 8
1 cm
55 50 25 30 35 40 45
Temperature (℃) Top view 3 mm
55℃
Agar
20 20 55
Temperature (℃) 25 30 35 40 45 Side view 3 mm
55 ℃ Agar
50 Air
Top view
2 mm Lesion
Side view
2 mm Top Side Lesion
Laser-guiding Smart Surgical Endoscope with Drug-loaded Functional Nanoparticles
Au nanorod Chlorin e6 Rhodamine B
Poly(N-isopropylacrylamide) Cetuximab Mesoporous silica shell
Doxorubicin PTT
50 μm PTT+chemo PDT
Combined
17
Com- bined
Cell viability (%
) 100
50
0
Ctrl. PDTPTT PTT chemo 50 73
43
99 N = 3
180 nm 300
100 200
Temperature (℃)
Size (nm)
20 30 40 50
Heating Cooling
Time (hr) 35 ℃ 65 ℃
Release (%)
0 10 20
100
50
0
50 ℃
Com- bined
Control PTT PTT+
chemo PDT
1 cm
Control PDT PTT PTT+chemo Combined
1 cm 1 cm 1 cm 1 cm 1 cm
Nature Communications 6,10059 (2015)
Laser guiding Optical
fiber
GP device
1 mm GP device
Metal device Tumor
Tumor
T umor V ol ume (mm
3)
1,500
Control
PDT PTT PTT+chemo Combined
0 500 1,000
Time (day)
0 5 10 15
N = 3
2,000
20 nm
Diabetes Mellitus
Diabetes
Chronic state of hyperglycemia due to deficiency of insulin secretion Current diagnosis / therapy procedure
Blood samples for test kits (e.g., Accu-chek) Insulin drug (oral) or shot
Hypoglycemia / Hyperglycemia
Abnormally diminished / Excessive glucose in the blood Hyperglycemic state (Too Much Glucose)
Hypoglycemic state (Need More Glucose)
Homeostasis
Overdose Symptoms
Pain Stress
Painless, Stress-free continuous glucose
monitoring & Feedback drug delivery!
Sweat-based Glucose Sensing
• Glucose in the sweat is
closely correlated with that in the blood
• Important factors that affect the sensing is different
between blood and sweat
• Blood: number of red blood cell, temperature, drug molecules
• Sweat: humidity, pH, temperature, drug molecules
Moyer, I. et al. Diabetes Technol. Ther. 14, 398-402 (2012)
A new integrated system is required for sweat-based glucose sensing.
Skin-based Diabetes Monitoring and Therapy
Nature Nanotechnology 11, 566 (2016)
GP-hybrid
a) functional materials (PEDOT, PB, PANi, Ag/AgCl) b) doped graphene
c) serpentine Au mesh a)
b)
c)
Oxi. Red.
ne-
ne-
Therapy
viii) micro-needles with drugs (PVP@PCM)
ix) heater (Au mesh/GP) x) temperature sensor (GP) i)
ii)
Therapy
iii) ~ vii)
viii) ~ x)
Sensing
to wireless unit Sensing
iii) humidity (PEDOT)
iv) glucose (PB) v) pH (PANi) vi) count. elect. (Ag/AgCl) vii) tremor (GP)
Sweat control i) sweat-uptake layer
(Nafion)
ii) water-proof film (silicone)
Sweat control
1 cm
Sensing Therapy
Compress (~20 %)
Stretch (~20 %) 2 mm
vii)
iv) iv)
vi) vi)
v) iii) v)
ix) x)
i) i)
ii) ii)
viii)
i)
1 mm 2 mm
In vivo Diabetes Monitoring Test
Sweat 2 mm
Diabetes patch
Wireless monitoring
1 cm
Portable Electrochemical Analyzer With Bluetooth Diabetes
patch Smart phone control/monitoring
2 cm
10 20
Time (min)
0 5 15
Measured RH (%)100
90 80 70 60 50
Wear
diabetes patch Start
measurement
Concentration (mM)
0 0.1 0.5
0 ΔI/I(%)o40
80 120
0.2 0.3 5
7 6 8 pH level
0.4 0.3
Temperature (°C)
Concentration (mM)
0 0.1 0.4
0 40 80 120
0.2 5
25 15
0.5 ΔI/Io(%)
N = 3
pH variation
Samples
Sweat pH
6.0 5.5 5.0 4.5
4.0 1 2 3 4
Subject 1 Subject 2
Blood glucose (Glucose meter)
Sweat glu. (mM)
0.18 Diabetes patch Glucose assay
Blood glu. (mg dL-1) 160 120
40 0.15
0.12 0.09
Time of day (hr)
14 16 17 18 19
12
11 13 15 20 21 22
Lunch Dinner
0.06
80
Breakfast
8 9 10 Cycle (number)
Sensitivity (a.u.)
2 4 6 8 10
0.5
00 1.0
Glucose pH
75
60
45 Sensitivity (mV pH-1)
Nature Nanotechnology 11, 566 (2016)
In vivo Transdermal Drug Delivery
R.T. T>Tc: transition
PVP/
drug Drug
elution PCM
25 40
Temperature (℃)
30 35
Left on Left/right on
Left on Initial
Left/right on
2 mm
Released drug (%)
Temperature (℃) 0
20 40 60
45 33 36 39 42
PCM Tc
T<Tc T>Tc 100
80
2 mm 250 μm
Micro-needles on heater
1 cm
Diabetic mouse 45
Temperature (℃)
30 35
4 mm
40 25
4 mm
Time after treatment (hr)
0 2 4 6
500 400 300 200 100
N = 6
no patch w/o drug w/ drug
*
P < 0.05* *
*
Blood glu. (mg dL-1)
45 (℃)
25 35 30 40
2 mm
i) ii)
iii) iv)
Turn on i) Turn on i)~ii) Turn on i)~iii) Turn on i)~iv)
Turn on i) Turn on i)~ii) Turn on i)~iii) Turn on i)~iv) Initial state
1 mm Heater
off Heater
on
IR sensor Temp. sensor
Time (min) 0
Temperature (℃)
40
30 35 45
1 2 3 4 5
- Thermo-actuated delivery - Stepwise delivery using an embedded multichannel heater
Nature Nanotechnology 11, 566 (2016)
Nanomaterials-based Soft Electronics
3 . Power Supply/Data Storage
- Power Generation Device - Long-term Power Supply - High Charge Capacity
1 . Hybrid-materials
- “Bottom-up” & “Top-down”
Hybrid Nanomaterials and Integration Processes
6 . Wireless System
- Wireless Power/
Data Transmission - Remote Control
2 . Sensors/Electronics
- Bio-Signal Measurement, In-Vivo - Physiological/Electrophysiological Mapping and Feedback Therapy
5 . Soft Substrates/Drug
- Biocompatible Materials - Good Adhesion to Tissue - Drug Delivery Function
- Minimizing strain during stretch or deformation - Low Temperature Process
4 . Stretchable Interconnect
- Ubiquitous High
Performance Diagnosis and Therapy System
7 . Wearable/Implantable System
Data Storage and User Interface??
“Wearable Flash Memory and QLEDs”
40 mm
CTFM array Voltage amplifier
ECG electrode
Heart rate detection Amplification Data storage
Stretching
10 mm 3 mm
Multiplexed CTFM Array 2 mm
300 μm
Word Line
Bit Line Connections for off-chip control
Wearable ECG Sensor, Amplifier, and Flash Memory
VSS
VDD VOUT VIN
GND 400 μm
GND Vin VSS
VDD
VOUT QT interval
Lead V5
ECG (mV)
Time T
P Lead V1
R
S P
R
S T
Q
0.5 s 100
50
-50 0
Threshold Voltage (V)
Retention Time (s) 0 200 400 600 800 1000 -4
-2 0 2 4 6 8
10 (P) 40V 0.1s
(P) 20V 0.1s (P) 30V 0.1s
(E) -40V 1s
Threshold Voltage (V)
1E0 1E1 1E2 P/E cycle (#) -2
0 2 4 6
1E3 1E4 (P) 30V 0.1s (E) -40V 0.1
s 1 MHz
20 1.0
0.0 0.2 0.4 0.6 0.8
-20 -10 0 10
Applied Voltage (V)
Normalized Cap. (A.U.)
Si Al2O3(Tox)
Trap Al2O3
(Box) Au electrode
30 Memory capacitors Au Film LB AuNP
AuNP Trap Type :
Science Advances 2, E1501101 (2016)
Electronic Patch: Sensing, Data Storage, and Transdermal DDS
Nature Nanotechnology 9, 397 (2014)
Epidermal, Water-proof Skin Optoelectronics
Nature Communications 6, 7149 (2015)
QLED Electronic Tattoo
Nature Communications 6, 7149 (2015)
Flat Wrinkled
3 mm 3 mm
Quantum Dot LEDs on Everything
Nature Communications 6, 7149 (2015)
Intaglio vs Structured Stamping
Repeat processes (6)
Pick-up QD layer (1)
Aligned transfer (5)
Transfer onto target surface (4)
Slowly detach (3)
Contact on intaglio trench (2)
QD PDMS
Surface treated substrate
Intaglio trench (5) Repeat
processes
Aligned transfer (4)
Structured PDMS stamp
Surface treated substrate
Contact on QD layer
Quickly pick-up QD layer (2) (1)
Transfer onto target substrate (3)
QD layer
Intaglio Printing Structured Stamping
Nature Communications 6, 7149 (2015)
Comparison between Stamping Methods
Nature Communications 6, 7149 (2015)
i ii
Flat stamp
QD layer
Edge of intaglio trench
Fraction of QD layer Crack initiation
Intaglio Printing
i ii
Edge of structured stamp
QD layer
ODTS treated substrate Crack initiation Crack propagation
Structured Stamping
HD : 1366× 768
→ 230 μm
Full HD : 1920× 1080
→ 150 μm
4K UHD : 3840× 2160
→ 75 μm
8K UHD : 7680× 4320
→ 35 μm
Structured stamping
Intaglio printing 40 inch
Flat panel display
60K UHD : 57600× 32400
→ 5 μm
70 μm
N. A.
25 μm
Intaglio printing
Yield distribution
transferred yield (%) 35 μm 150 μm 75μm
20 40 60 100
0 0.4
0 0.6 0.8 1.0
0.2
80 Square patterns
Structured stamping
35 μm 150 μm 75μm
Line patterns
Transferred area (%)
Structured stamping Intaglio printing
Line width (μm) 20 40 60 80 100 0
100
0 90
Ultrahigh Resolution RGB Patterning
Nature Communications 6, 7149 (2015)
Ultrahigh Resolution RGB Patterning
Nature Communications 6, 7149 (2015) VR
(HMD)
retina resolution in VR needs a display of →
2500 ppi (>1500) LCD Small Aperture
(Brightness ) <1000 ppi
OLED Shadow Mask
(Definition ) <1000 ppi QLED OLED Advantages
High Resolution 2460 ppi
iPhone 6 (326 ppi) Galaxy S6 (577 ppi)
LCD OLED
QLED
520 540
560 580
600630 510
490 470
PWQLED
iii
i ii
ii
iii
100 μm 10 μm 100 μm 10 μm
10 μm
100 μm
i
5 mm